Researchers used Truveta Data from over 40,000 patients to assess whether newer GLP-1 RA medications semaglutide and tirzepatide, commonly known by brand names Ozempic, Wegovy, Mounjaro, and Zepbound are associated with lower risks of emergency department visits and hospitalizations related to alcohol use
However, certain foods can stimulate your body to produce more of its own GLP-1 naturally
Extended escalation for sensitive patients Some patients metabolize tirzepatide more slowly or have greater sensitivity to GI side effects
Modulation of excitatory synaptic transmission by GABA C receptor-mediated feedback in the mouse inner retina
For higher doses (4 mg and above), the medication is typically started at a lower dose (2 mg or 4 mg) and gradually built up to reduce the potential for gastrointestinal side effects
Compounded GLP-1 Receptor Agonists: Opportunity for Compassionate Conversation